ArriVent
Pennsylvania Furnace
About ArriVent
ArriVent is a biopharmaceutical company developing pharmaceutical products to cure presently untreatable cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $455.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nasdaq:AVBP
- Website: arrivent.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/arrivent-30113 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.